Health Care: Drugs

Theravance Inc (THRX: NASDAQ)

$11.27 n/a | n/a%
01/30/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 11.27
52 Week High 32.88
52 Week Low 10.60
Avg. Daily Vol. (Mil) 0.96
Beta (3 year) 1.73
Share Related Items
Mkt Cap (Mil) 1,300.21
Shares Out (Mil) 115.37
Float (Mil) 46.19
Dividend Information
Yield % 4.40
Annual Dividend 0.50
Payout Ratio n.a.
Financial Strength
Quick Ratio 7.40
Current Ratio 7.60
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 347.09
Price/Book 0.00
Price/Cash Flow -6.90
Per Share Data
Earnings -1.84
Sales 0.03
Book Value 0.00
Cash Flow -1.63
Business Summary
Theravance Inc., is a biopharmaceutical company with a pipeline of internally discovered product candidates and collaborations with pharmaceutical companies.
General Information
901 Gateway Boulevard
South San Francisc, CA 94080
Industry : Drugs
Sector: Health Care
Employees: 241
CEO: Michael W. Aguiar
Short Interest
Current Month (Mil) 25.44
Previous Month (Mil) 25.91
Short Interest Ratio (Days) 25.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -36.60
Return on Investments -39.50
Gross Margin 95.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with THRX

Latest THRX Headlines from TheStreet

More Financial News for THRX

Press Releases for THRX

See All Press Releases

Partner Headlines for THRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter